Publications by authors named "Anne-Mie Bael"
Am J Clin Pathol
November 2012
Article Synopsis
- The World Health Organization has added flow cytometry to help diagnose myelodysplastic syndromes (MDS), focusing on abnormal antigen expression in bone marrow blasts to identify low-grade MDS.
- This study analyzed 175 patients to compare antigen expression in CD34+ bone marrow cells from those diagnosed with MDS versus those with secondary cytopenia, including markers like CD34, CD117, and CD123.
- Findings showed that a high percentage of CD34+ cells and certain overexpressed markers, along with abnormal CD45 expression, serve as effective indicators for MDS and reflect similarities with CD34+ acute myeloid leukemia (AML).
